Journal of Clinical and Experimental Ophthalmology
Open Access

Salvatore Cillino

Publications

• Case Report
  Intravitreal Pegaptanib in Ischemic CRVO Refractory Exudative Macular Detachment
  Author(s): Giovanni Cillino and Salvatore CillinoGiovanni Cillino and Salvatore Cillino
  
  Recent literature data reported evidence of the visual and/or anatomical benefits of all clinically available anti-VEGF drugs for the treatment of macular edema (ME) following Central Retinal Vein Occlusion (CRVO), up to 1-year followup. There are no randomized clinical trial data on anti-VEGF agents in ischemic CRVO-ME and the use of anti-VEGF agents to treat this condition. A 73-year old caucasian man, with a medical history of diabetes and systemic hypertension and an ophthalmic history of ischemic CRVO with cystoid macular edema was referred to our division on January 2011. The ophthalmic examination showed in right eye a visual acuity of 20/2000, a C2N1 cataract and an exudative macular detachment. On February 2011, a 0.5mg ranibizumab intravitreal injection (Lucentis®, Novartis, Basel, Switzerland) was carried out in the right eye. 15 and 25 days later the OCT showed .. View More»
  DOI: 10.4172/2155-9570.1000202

  Abstract PDF

Relevant Topics